2-[5-[(Acryloyloxy)methyl]-5-ethyl-1,3-dioxan-2-yl]-2-methylpropyl Acrylate (cis- and trans- mixture) (stabilized with MEHQ)>95.0%(qNMR)25g

3-(4-Bromophenyl)-1-phenyl-1H-pyrazole-4-carboxaldehyde, 95.0%, 250mg

(2-Methyl-[1,1'-biphenyl]-3-yl)methanol, 95.0%, 1kg

(4R,5S)-5-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-4-METHYL-1,3-OXAZOLIDIN-2-ONE, 95.0%, 1g

Furo[3,2-b]pyridin-6-ol, 97%, 2g

Dimethyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)phosphine oxide, 97%, 1g

1-(ethylcarbamothioyl)piperidine-4-carboxylic acid, 95.0%, 250mg

2-(3-(2,4-Difluorophenyl)-4,5-dihydroisoxazol-5-yl)-1-morpholinoethan-1-one, 97%, 25mg

Albumine sérique bovine (BSA) Fraction V, sans IgG, origine Nouvelle-Zélande, 50 g

1-(6-((Benzyloxy)bis(4-methoxyphenyl)methyl)-4-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-5-hydroxytetrahydro-2H-pyran-3-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95%, 100mg

3-Anilinoacraldehyde anil hydrochloride salt, 98.0%, 250mg

(S)-N-(Tetrahydro-2H-pyran-3-yl)benzamide, 90.0%, 250mg

(4-Chloropyrimidin-5-yl)methanol, 98%, 1g